Suivre
Abonner Gerresheimer AG
Filtre
  • 08.04.2021 – 08:53

    Gerresheimer with positive start to the financial year 2021

    Duesseldorf, Germany (ots/PRNewswire) - - Organic revenue growth of 3.1 % in core business - Strong development in High Value Solutions: Focus on Biological Solutions pays off - Adjusted EBITDA increases organically by 7.0 % in core business - Adjusted earnings per share rise organically by 29.3 % to EUR 0.57 - Guidance confirmed for the financial year 2021 "We got off to a good start in the financial year," said Dietmar ...

  • 13.10.2020 – 07:33

    Gerresheimer on track for strong second half-year

    Dusseldorf, Germany (ots/PRNewswire) - - Third quarter on schedule - Group revenues EUR 349m; 2.1% organic revenue growth in core business - Adjusted EBITDA increases by 4.1% to EUR 75m - Significant improvement in free cash flow to EUR 38m - Strong fourth quarter 2020 expected - Guidance for 2020 confirmed Gerresheimer AG delivered profitable growth in its core business in the third quarter of 2020 and confirmed its ...

  • 24.06.2020 – 16:44

    Annual General Meeting of Gerresheimer AG Approves Dividend Increase to EUR 1.20 per Share

    Duesseldorf, Germany (ots/PRNewswire) - Payment of a dividend of EUR 1.20 per share was approved at the virtual Annual General Meeting of Gerresheimer AG. "In 2019, we paved the way for profitable growth and achieved a substantial improvement in the Company's culture and dynamic. We are investing and working to grow our innovation pipeline. These efforts continue ...

  • 19.11.2019 – 13:38

    New Focus in Project Portfolio of Gerresheimer Subsidiary Sensile Medical

    Dusseldorf, Germany (ots/PRNewswire) - - SQ Innovation and Gerresheimer sign partnership for micro pumps for heart failure treatment - Sanofi terminates development project for micro pumps for patients with diabetes - Further projects with pharma customers for various therapy areas for the micro pump started Sensile Medical, a subsidiary of Gerresheimer AG, has signed ...

  • 11.07.2019 – 08:10

    Gerresheimer Reports Strong Second Quarter

    - Revenues up 7.2% on the prior-year quarter to EUR 356.5m - Adjusted EBITDA at EUR 74.2m in second quarter of 2019 (Q2 2018: EUR 71.1m), excluding EUR 26.2m from derecognition of contingent purchase price compo­nents in connection with Sensile Medical acquisition - Revenue guidance confirmed without change; guidance on adjusted EBITDA at constant exchange rates for the financial year 2019 approximately EUR 295m (plus ...

  • 14.05.2019 – 10:31

    Dr. Bernd Metzner to Become Chief Financial Officer of Gerresheimer AG on May 15, 2019

    Duesseldorf, Germany (ots/PRNewswire) - Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014. "I very much welcome the financial expertise and years of industry experience that Dr. Bernd Metzner brings to the Management ...

  • 11.10.2018 – 08:05

    Gerresheimer Increases Revenues by 8.8% and Successfully Integrates Sensile Medical

    Düsseldorf, Germany (ots/PRNewswire) - - Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m - Adjusted EBITDA at constant exchange rates-excluding Sensile Medical and negative effects relating to the exemption from electricity network charges-increased by EUR 1.3m in third quarter to EUR 79.5m - Integration of Sensile Medical proceeding ...

  • 14.04.2010 – 07:30

    Good start to the year for Gerresheimer

    Düsseldorf (ots) - - Group sales in the first quarter up 1.4% on like-for-like basis - Profit from operations grew by 34% to EUR 12.3m - Reiteration of guidance for the financial year 2010 Gerresheimer AG has got off to a good start in the new financial year. In the first quarter (December 2009 to February 2010), sales increased by 1.4% on a like-for-like basis and amounted to EUR 224.8m. ...